On April 13, both the Centers for Disease Control and Prevention and the United States Food and Drug Administration recommended a pause in the use of the Johnson & Johnson's Janssen COVID-19 vaccine "out of an abundance of caution." The CDC and FDA are reviewing data after six people out of the nearly 7 million…
